A randomized prospective clinical trial comparing pegylated interferon alpha 2a/ribavirin versus pegylated interferon alpha 2b/ribavirin in the treatment of Chronic Hepatitis C

被引：10
|
作者：
Sinha, S [1 ]
Gulur, P [1 ]
Patel, V [1 ]
Hage-Nassar, G [1 ]
Tenner, S [1 ]
机构：
[1] Suny Downstate Med Ctr, New York, NY USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2004年 / 99卷 / 10期
关键词：
D O I：
10.14309/00000434-200410001-00236
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
237
引用
收藏
页码：S77 / S78
页数：2
相关论文
共 50 条
  • [1] Pegylated Interferon-α2a and Ribavirin versus Pegylated Interferon-α2b and Ribavirin in Chronic Hepatitis C A Meta-Analysis
    Flori, Nicolas
    Funakoshi, Natalie
    Duny, Yohan
    Valats, Jean-Christophe
    Bismuth, Michael
    Christophorou, Dimitri
    Daures, Jean-Pierre
    Blanc, Pierre
    [J]. DRUGS, 2013, 73 (03) : 263 - 277
  • [2] Pegylated interferon α2a plus ribavirin versus pegylated interferon α2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients
    Berenguer, J.
    Gonzalez-Garcia, J.
    Lopez-Aldeguer, J.
    Von-Wichmann, M. A.
    Quereda, C.
    Hernando, A.
    Sanz, J.
    Tural, C.
    Ortega, E.
    Mallolas, J.
    Santos, I.
    Miralles, P.
    Montes, M. L.
    Bellon, J. M.
    Esteban, H.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (06) : 1256 - 1263
  • [3] Randomized Trial Comparing Pegylated Interferon α-2b Versus Pegylated Interferon α-2a, Both Plus Ribavirin, to Treat Chronic Hepatitis C in Human Immunodeficiency Virus Patients
    Laguno, Montserrat
    Cifuentes, Carmen
    Murillas, Javier
    Veloso, Sergio
    Larrousse, Maria
    Payeras, Antoni
    Bonet, Lucia
    Vidal, Francesc
    Milinkovic, Ana
    Bassa, Antoni
    Villalonga, Concha
    Perez, Inaki
    Tural, Cristina
    Martinez-Rebollar, Maria
    Calvo, Marta
    Luis Blanco, Jose
    Martinez, Estaban
    Sanchez-Tapias, Jose M.
    Gatell, Jose M.
    Mallolas, Jose
    [J]. HEPATOLOGY, 2009, 49 (01) : 22 - 31
  • [4] Pegylated Interferon-α2a and Ribavirin versus Pegylated Interferon-α2b and Ribavirin in Chronic Hepatitis CA Meta-Analysis
    Nicolas Flori
    Natalie Funakoshi
    Yohan Duny
    Jean-Christophe Valats
    Michael Bismuth
    Dimitri Christophorou
    Jean-Pierre Daurès
    Pierre Blanc
    [J]. Drugs, 2013, 73 : 263 - 277
  • [5] Pegylated interferon alpha 2b (PEG-IFN) plus ribavirin (RBV) versus pegylated interferon alpha 2b for chronic hepatitis C in HIV patients
    Cargnel, A
    Angeli, E
    Mainini, A
    Gubertini, G
    Giorgi, R
    Orlando, G
    Duca, P
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A766 - A766
  • [6] Efficacy and tolerability of pegylated interferon alpha-2a plus ribavirin versus pegylated interferon alpha-2b plus ribavirin, in treatment naive chronic hepatitis C patients
    Lee, S. Y.
    Lee, S.
    Ko, K. S.
    Kim, I. H.
    Kim, S. H.
    Kim, S. W.
    Lee, S. O.
    Lee, S. T.
    Kim, D. G.
    Choi, C. S.
    Cho, E. Y.
    Kim, H. C.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A176 - A176
  • [7] Cost effectiveness of pegylated interferon alpha 2b and ribavirin combination in chronic hepatitis C
    Poynard, T
    [J]. GUT, 2003, 52 (10) : 1532 - 1532
  • [8] Triple combination of pegylated interferon alpha 2b, ribavirin and amantadine for treatment of chronic hepatitis
    Younossi, ZM
    McCullough, AJ
    Barnes, DS
    Post, A
    Ong, JP
    Mullen, KD
    Carey, WD
    O'Shea, R
    Levinthal, G
    Gramlich, T
    Martin, LM
    Bringman, D
    Tavill, A
    Ferguson, R
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A781 - A781
  • [9] A randomized trial of pegylated interferon α-2b plus ribavirin in the retreatment of chronic hepatitis C
    Jacobson, IM
    Gonzalez, SA
    Ahmed, F
    Lebovics, E
    Min, AD
    Bodenheimer, HC
    Esposito, SP
    Brown, RS
    Bräu, N
    Klion, FM
    Tobias, H
    Bini, EJ
    Brodsky, N
    Cerulli, MA
    Aytaman, A
    Gardner, PW
    Geders, JM
    Spivack, JE
    Rahmin, MG
    Berman, DH
    Ehrlich, J
    Russo, MW
    Chait, M
    Rovner, D
    Edlin, BR
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (11): : 2453 - 2462
  • [10] Treatment of chronic hepatitis C in HIV infected patients (pts) with pegylated interferon alpha 2b (PEG-IFN) plus ribavirin (RBV) versus pegylated interferon alpha 2b
    Cargnel, A
    Angeli, E
    Mainini, A
    Casella, A
    Gubertini, G
    Giorgi, R
    Orlando, G
    Duca, PG
    [J]. JOURNAL OF HEPATOLOGY, 2003, 38 : 132 - 132
12345